Comprehensive additional training is necessary in Germany, to specialise in paediatric radiology, and only seven among the country’s 35 university hospitals provide paediatric radiology professorships. Thus, there are only about 80 specialists in this field and very few work in private practice
Participants at European Health Forum Gastein 2011 (EHFG) agreed: the tendency in Germany and Austria is to operate far too soon (particularly for hip, knee and disc surgery), and many surgical interventions are unnecessary, posing a particular and increasingly urgent problem especially in industrialised countries. Hans-Christian Pruszinsky reports
On 21 September 2011, in a lunch debate held at the European Parliament in Brussels EPF, CPME, PGEU and EFPIA brought together the perspectives of patients, doctors, community pharmacists and the research-based pharmaceutical industry presenting examples of best practices on adherence to therapies, and demonstrating how a coordinated, multi-stakeholder and patient-centred approach – involving…
Improving the quality of healthcare, increasing the efficiency of the systems and ensuring patient empowerment - these are the common goals worldwide when discussing the necessary transformation of the systems in order to guarantee a sustainable healthcare delivery in the future. The Global E-Health Forum - Hamburg 2011 will represent major stakeholders involved in designing personalized…
Debuting at the AACC meeting was the first free mobile application to help consumers decipher their own medical tests. Created for use on an iPhone, iPad and Android smartphone, the Lab Tests Online app connects to a site promising to provide reliable, unbiased information that enables them to have more informed conversations with their doctors.
Founded in 1998, the European Health Forum Gastein (5-8 October, Salzburg, Austria) is Europe’s leading health political conference, attracting 600 participants from around 60 countries. Beyond the EU, its leading role is underlined by the participation of active members from the GUS states, south-eastern European countries and Taiwan, Christian Pruszinsky reports.
Visiting European healthcare professionals will be able to enter a strong debate on hospital-related politics as well as medical and economic issues at MEDICA this year when the 1st European Hospital Conference (EHC) will take place at 18th November alongside the 34th Congress of German Hospitals.
The 1st European Hospital Conference (EHC) will see three important organisations face up to their differences in what promises to be a great debate: During our interview with Dr João de Deus, President of the European Association of Senior Hospital Physicians (AEMH), he pointed out that AEMH, the European Hospital and Healthcare Federation (HOPE) and the European Association of Hospital…
Yes, it’s in beautiful Dresden again and -- as in 2006 when the city last hosted the Congress of the German Society for Senology -- this year’s Congress President is Professor Rüdiger Schulz-Wendtland (Department of Radiology, University of Erlangen). However, the repetition ends there; the congress topics will be anything but repeated. Report: Meike Lerner
‘Heal the world’ sang the Berliner Rundfunk Children’s Choir and Youth Orchestra, and thus aptly began the joint 21st International Congress of Clinical Chemistry and Laboratory Medicine and the 19th IFCC-EFCC European Congress of Clinical Chemistry and Laboratory Medicine, attracting 4,418 delegates, 2,833 visitors and 1,058 exhibiting staff to Berlin in May.
Having cancer is an extremely complex experience for those people concerned. Alongside the purely physiological aspects, those suffering from cancer find themselves in a highly threatening and an entirely different situation in life. In the past, classical medicine has concentrated on the treatment of the carcinogenous changes. But what role does the patient’s psyche play in treating the…
France – Re-opening clogged arteries with metal stents has proved a life-saver for a majority of patients with coronary disease. Yet the high rates of complications and mortality for patients with diabetes following a percutaneous coronary intervention (PCI) continue to baffle cardiologists. Report: John Brosky
Although powerful, new, targeted treatments are regularly introduced to cancer clinics, choices for the first-line treatment of invasive breast cancer normally lie between preventive surgery and chemotherapy. A recent American study used genomic prediction combining multiple signatures to determine outcomes to standard chemotherapy.
Facing the fundamental changes that laboratory medicine is undergoing, in early June Roche Diagnostics Deutschland GmbH invited 50 high-profile speakers to a six-day symposium to discuss current research, economic and diagnostic issues in lab medicine with a professional audience. Report: Karoline Laarmann
It turns out to be difficult to find out exactly how much a child who cannot yet speak suffers after a surgical operation. Researchers at the University Hospital of La Paz, in Madrid, have validated the 'Llanto' scale, the first, and only, tool in Spanish which measures infant pain rapidly and simply.
‘Three years is a long time in the world of research. The amount of information on offer quickly grows quite enormously,’ says Professor Rudolf Tauber, joint head of this year’s WorldLab congress with Professor Harald Renz. Thus, one organisational challenge was to channel current trends and developments and present participants with an informative, comprehensive overview. How was this…
In the first month of 2011, the Centre for Pharmacogenetics and Pharmacogenomics at the Paracelsus Private Medical University in Salzburg, Austria, officially opened its doors. Why have pharmacogenetics and pharmacogenomics so increasingly important in medical research? We asked the head of the new research centre, Professor Markus Paulmichl.
It’s a war against a perceived enemy that is not – autoimmune disease like rheumatoid arthritis, lupus erythematosus or multiple sclerosis, occur when the immune system attacks normal tissue components. Characteristic of those disease patterns are autoantibodies in the blood, which the immune system produces to attack its own organism.
Over 8,000 international clinicians and scientists travelled to Berlin in March to attend the International Liver Congress 2011, hosted by The European Association for the Study of the Liver (EASL), to hear the latest research, perspectives and treatments in hepatology.
The birth, in France, of its first baby to be conceived by artificial insemination on top of the selection of an embryo based on its blood, has sent new flames into the hot parliamentary debate over the reform of bioethics law.
A specially customised pulse oximeter attached to the finger can be used to detect changes in heart and vessel function while you sleep, and this simple technique can even identify patients at increased risk of cardiovascular disease, reveals research from the University of Gothenburg, Sweden.
Breast cancer can develop very differently in different women. Researchers in Norway are improving breast cancer diagnostics and treatment by identifying the various tumour types. The objective is to find out as much as possible about the various tumour types so that each patient can receive precisely the right treatment at the right time.
Molecular imaging (MI) is reported as an increasingly important diagnostic field for radiologists to focus on. However, molecular imaging should not be considered a new discipline that only adds to today’s clinical practice, or might even replace the traditional, more morphology-oriented diagnosis. Rather, the whole diagnostic concept should be re-considered.
A leading radiologist is forecasting a ‘paradigm shift’ in breast imaging. Dr Peter Brader, from Department of Radiology, Division for Molecular and Gender Imaging, Medical University Vienna, envisages that diagnosis and treatment will move from a ‘one size fits all’ approach to one of personalised molecular medicine by 2025. He also foresees greater use of theranostics with combinations…
Cornelis Van De Velde, Professor of Surgical Oncology at the Leiden University Medical Centre, in the Netherlands, and President of the European Society of Surgical Oncology (ESSO), describes the work and aims of the society within the EU.
